Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Airway Clearance Vest Improves Respiratory Function

By HospiMedica International staff writers
Posted on 24 Sep 2013
A novel chest wall-oscillation vest benefits chronic lung disease patients by dramatically improving cough productivity and ease of breathing.

The AffloVest is a portable High Frequency Chest Wall Oscillation (HFCWO) device intended for patients with chronic lung conditions such as severe chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis (CF), and other related ailments. More...
The lightweight device, which weighs approximately 4 kg, provides adjustable levels of treatment intensity and multiple treatment modes. Doctors and patients can tailor treatments to their needs, with nine possible settings that provide chest wall-oscillation treatment on both the front and back of the vest.

To use the device, the patient slips the vest on, buckles three clips, and tightens the straps to ensure a secure fit. Then, depending on individual treatment needs, the patient chooses the setting using a handheld control attached to the right side of the vest. A battery pack provides power for mobile treatments, but the device also includes an AC adapter which allows it to be run indefinitely from a power outlet should longer treatment periods be required. The AffloVest is a made by International Biophysics Corporation (IBC; Austin, TX, USA), and is available in five sizes (XS, S, M, L, and XL) for both children and adults with chronic lung conditions.

“Other airway clearance vests tether the patient by an air hose to bulky machines that must be plugged into a wall,” said David Shockley, president of IBC. “The AffloVest is the market’s first portable, battery-operated HFCWO vest. Users can move about freely—even travel—during treatments, or sit comfortably in any position, even while lying down.”

“With every single patient, a dramatic improvement in cough productivity and bronchial secretion viscosity was observed, in combination with the pulmonary and orthopedic regimen of care,” said Konrad Schultz, MD, of the Bad Reichenhall Clinic (Munich, Germany). “It became fundamentally easier for the patients to cough out mucus, because of the more fluid secretions and more productive cough provided by the introduction of High Frequency Chest Wall Oscillation treatment with the AffloVest.”

HFCWO assist devices generate either positive or negative trans-respiratory pressure excursions to produce high frequency, small-volume oscillations in the airways. The oscillations can lead to changes in volume of 15–57 mL and in flow up to 1.6 L/s, which generate minimal coughing to mobilize secretions. Typical treatment last 20–30 minutes, and consists of short periods of compression at different frequencies, separated by coughing.

Related Links:

International Biophysics Corporation
Bad Reichenhall Clinic



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.